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We have developed an integrated continuous processing framework for end-to-end production of complex
fragile proteins based on perfusion cultivation and automated multi-step purification [1,2]. Upstream, the
integrated system consists of a stirred tank bioreactor with an ATF cell retention system. The clarified harvest
directly enters an off-the-shelf ÄKTA chromatography system converted into a continuous purification unit. Two
alternating capture columns precede a multi-step purification train with full flexibility and control of individual
columns.
The integrated set-up enables compact automated bench-top factories converting cell culture media to purified
protein in an efficient manner without intermediate storage. It provides monitoring of the production progress
allowing for “just-enough” production and better use of resources. Importantly, the integrated approach also
enables continuous monitoring of product quality attributes. This aspect is obviously relevant in a manufacturing
setting but perhaps even more so during process development to aid deciphering the relation between cell
culture performance and product quality.
Case studies from production of fragile proteins for pre-clinical supply will be presented. As an example of
process intensification, the combination of the integrated continuous framework with a novel perfusion platform
enabled laboratory-scale equipment to produce amounts that previously would have required pilot-scale
resources. Examples with disturbances and/or deliberate changes and/or in the cell culture process during
integrated processing will be given to illustrate the monitoring benefits from an upstream perspective.
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